X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28) 28
index medicus (19) 19
oncology (19) 19
female (18) 18
male (15) 15
colorectal cancer (14) 14
middle aged (14) 14
adult (11) 11
aged (11) 11
chemotherapy (11) 11
cancer (9) 9
treatment outcome (9) 9
neoadjuvant therapy (8) 8
aged, 80 and over (7) 7
care and treatment (7) 7
disease-free survival (7) 7
drug therapy (7) 7
neoplasm staging (7) 7
surgery (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
oxaliplatin (6) 6
patient outcomes (6) 6
prognosis (6) 6
rectal cancer (6) 6
rectal neoplasms - pathology (6) 6
retrospective studies (6) 6
antineoplastic agents - therapeutic use (5) 5
fluorouracil (5) 5
medicine & public health (5) 5
survival rate (5) 5
adenocarcinoma - therapy (4) 4
analysis (4) 4
bevacizumab (4) 4
biomarkers, tumor - genetics (4) 4
chemoradiotherapy (4) 4
colorectal neoplasms - drug therapy (4) 4
fluorouracil - administration & dosage (4) 4
hematology, oncology and palliative medicine (4) 4
leucovorin (4) 4
leucovorin - administration & dosage (4) 4
metastasis (4) 4
neoplasm recurrence, local (4) 4
rectal neoplasms - therapy (4) 4
research (4) 4
survival (4) 4
time factors (4) 4
usage (4) 4
adenocarcinoma - secondary (3) 3
adolescent (3) 3
angiogenesis (3) 3
angiogenesis inhibitors (3) 3
animals (3) 3
cancer therapies (3) 3
chemoradiotherapy, adjuvant - adverse effects (3) 3
child (3) 3
colon-cancer (3) 3
colorectal surgery (3) 3
complete clinical-response (3) 3
complete response (3) 3
development and progression (3) 3
follow-up studies (3) 3
gastroenterology & hepatology (3) 3
gastroenterology and hepatology (3) 3
hepatoma (3) 3
immunology (3) 3
immunotherapy (3) 3
kaplan-meier estimate (3) 3
liquid biopsies (3) 3
liver neoplasms - blood (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
patient selection (3) 3
pd-1 blockade (3) 3
preoperative radiotherapy (3) 3
proctology (3) 3
recurrence (3) 3
therapy (3) 3
transanal endoscopic microsurgery (3) 3
vascular endothelial growth factor (3) 3
young adult (3) 3
adenocarcinoma (2) 2
adenocarcinoma - blood (2) 2
adenocarcinoma - drug therapy (2) 2
adenocarcinoma - genetics (2) 2
adenocarcinoma - pathology (2) 2
adenocarcinoma - radiotherapy (2) 2
adjuvant chemotherapy (2) 2
adjuvant treatment (2) 2
aflibercept (2) 2
angiogenesis inhibitors - therapeutic use (2) 2
antibodies, antinuclear - analysis (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
area under curve (2) 2
articles (2) 2
biomarkers, tumor - blood (2) 2
biopsy - methods (2) 2
blood (2) 2
brazil - epidemiology (2) 2
cancer patients (2) 2
cancer-gene panels (2) 2
carcinoma (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 20, pp. 2619 - 2626
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 33, pp. 34221 - 34227
Cancer gene panels (CGPs) are already used in clinical practice to match tumor's genetic profile with available targeted therapies. We aimed to determine if... 
PD-1 blockade | Mutational load | Immunotherapy | Response prediction | Cancer-gene panels | mutational load | cancer-gene panels | response prediction | MICROSATELLITE INSTABILITY | immunotherapy | TUMOR | NIVOLUMAB | IPILIMUMAB | LYMPHOCYTES | ANTIGEN | CELL BIOLOGY
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 489 - 489
489 Background: Cytotoxic chemotherapy with FOLFIRINOX (5-Fluoracil + Irinotecan + Oxaliplatin) is considered the standard treatment for fit patients (pts)... 
Journal Article
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 03/2019, Volume 9, p. 170
Background: Anti-EGFR antibodies are a standard care for advanced KRAS-wild type colorectal cancers. Circulating tumor DNA (ctDNA) monitoring during therapy... 
colorectal cancer | ACQUIRED-RESISTANCE | monitoring | HETEROGENEITY | EVOLUTION | ONCOLOGY | liquid biopsies | RAS MUTATIONS | FOLFIRI PLUS CETUXIMAB | anti-EGFR therapy | drug resistance | BLOCKADE | circulating tumor DNA | BLOOD | Gene mutations | Panitumumab | Colorectal cancer | Dosage and administration | Genetic aspects | Research | Drug therapy
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 10114 - 10114
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e15513 - e15513
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e21676 - e21676
Journal Article
Annals of Surgery, ISSN 0003-4932, 10/2004, Volume 240, Issue 4, pp. 711 - 718
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.